Site Map
Site Map of
http://www.researchandmarkets.com
-
Site Map
-
Pharmaceuticals and Healthcare
-
Pharmaceuticals 1
(
Latest Titles
)
Pharmaceuticals 2
Pharmaceuticals 3
Pharmaceuticals 4
<< You are in This Category
-
Companies
-
Drug Delivery
-
Markets
-
OTC
-
Respiratory
-
Vitamins
-
Drug Discovery
-
Technology
-
E-Healthcare
-
Cardiovascular
-
Central Nervous System
-
Generics
-
Genomics
-
Immune Disorders
-
Infectious Diseases
-
Oncology
-
Pharmacoeconomics
-
Women's Health
-
Fast Facts
-
Analgesics
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
^ Top
T
The Market for Antibodies: Keys to Success for Commercial Suppliers, Volume II
static version
printer friendly
pdf version
The Market for Neurotechnology: 2008-2012
static version
printer friendly
pdf version
The Market for Pharmaceuticals in Brazil, Russia, India & China 2008
static version
printer friendly
pdf version
The Multi-platform Healthcare Consumer: Europe’s Interactive Opportunities in 2001 and Beyond
static version
printer friendly
pdf version
The National Institute of Clinical Excellence in CNS: A Major Impact on the European Market
static version
printer friendly
pdf version
The OTC Market in Poland 2006
static version
printer friendly
pdf version
The Outlook for Pharmaceuticals in Central & Eastern Europe to 2013
static version
printer friendly
pdf version
The Outlook for Pharmaceuticals in Latin America to 2013
static version
printer friendly
pdf version
The Outlook for Pharmaceuticals in Northern Europe to 2013
static version
printer friendly
pdf version
The Outlook for Pharmaceuticals in South East Asia to 2013
static version
printer friendly
pdf version
The Outlook for Pharmaceuticals Worldwide to 2013
static version
printer friendly
pdf version
The Outlook For RNAi: Accelerating Drug Discovery and the Development of RNAi Therapeutics
static version
printer friendly
pdf version
The Pain Market Outlook to 2011
static version
printer friendly
pdf version
The Pharma R&D Fact Book 2007
static version
printer friendly
pdf version
The Pharmaceutical Company Outlook to 2011: Financial and Strategic Analysis of the Sales Outlook for Big Pharma, Mid Pharma, Japan Pharma and Biotech
static version
printer friendly
pdf version
The Pharmaceutical Deals of 2006 - Lessons for 2007
static version
printer friendly
pdf version
The Pharmaceutical Industry 1999 - Japan
static version
printer friendly
pdf version
The Pharmaceutical Industry 2003 - Japan
static version
printer friendly
pdf version
The Pharmaceutical Industry 2005
static version
printer friendly
pdf version
The Pharmaceutical Industry 2008: Current and Future Trends and Strategic Issues Shaping Pharma
static version
printer friendly
pdf version
The Pharmaceutical Industry Paradox: A Strategic Analysis Of The Countertrends Of Consolidation And Fragmentation
static version
printer friendly
pdf version
The Pharmaceutical Industry: Key Events and Trends Shaping its Current Status and Future Direction
static version
printer friendly
pdf version
The Pharmaceutical Industry: Key Trends and Strategic Issues Shaping the Industry.
static version
printer friendly
pdf version
The Pharmaceutical Licensing Outlook: A Strategic Guide To Effective Deal-Making And Profitable Partnerships
static version
printer friendly
pdf version
The Pharmaceutical Market Outlook to 2015: Implementing innovative, long-term strategies for sustainable future growth
static version
printer friendly
pdf version
The Pharmaceutical Market: Argentina
static version
printer friendly
pdf version
The Pharmaceutical Market: Australia
static version
printer friendly
pdf version
The Pharmaceutical Market: Austria
static version
printer friendly
pdf version
The Pharmaceutical Market: Bangladesh
static version
printer friendly
pdf version
The Pharmaceutical Market: Belgium
static version
printer friendly
pdf version
The Pharmaceutical Market: Bulgaria
static version
printer friendly
pdf version
The Pharmaceutical Market: Canada
static version
printer friendly
pdf version
The Pharmaceutical Market: Chile
static version
printer friendly
pdf version
The Pharmaceutical Market: China
static version
printer friendly
pdf version
The Pharmaceutical Market: Colombia
static version
printer friendly
pdf version
The Pharmaceutical Market: Croatia
static version
printer friendly
pdf version
The Pharmaceutical Market: Cuba
static version
printer friendly
pdf version
The Pharmaceutical Market: Czech Republic
static version
printer friendly
pdf version
The Pharmaceutical Market: Denmark
static version
printer friendly
pdf version
The Pharmaceutical Market: Egypt
static version
printer friendly
pdf version
The Pharmaceutical Market: Estonia
static version
printer friendly
pdf version
The Pharmaceutical Market: Finland
static version
printer friendly
pdf version
The Pharmaceutical Market: France
static version
printer friendly
pdf version
The Pharmaceutical Market: Germany
static version
printer friendly
pdf version
The Pharmaceutical Market: Hong Kong
static version
printer friendly
pdf version
The Pharmaceutical Market: Hungary - 2007 Update
static version
printer friendly
pdf version
The Pharmaceutical Market: India
static version
printer friendly
pdf version
The Pharmaceutical Market: Indonesia
static version
printer friendly
pdf version
The Pharmaceutical Market: Ireland
static version
printer friendly
pdf version
The Pharmaceutical Market: Israel
static version
printer friendly
pdf version
The Pharmaceutical Market: Italy
static version
printer friendly
pdf version
The Pharmaceutical Market: Japan
static version
printer friendly
pdf version
The Pharmaceutical Market: Jordan - 2007 Update
static version
printer friendly
pdf version
The Pharmaceutical Market: Latvia
static version
printer friendly
pdf version
The Pharmaceutical Market: Lithuania
static version
printer friendly
pdf version
The Pharmaceutical Market: Malaysia
static version
printer friendly
pdf version
The Pharmaceutical Market: Malta
static version
printer friendly
pdf version
The Pharmaceutical Market: Mexico
static version
printer friendly
pdf version
The Pharmaceutical Market: Morocco
static version
printer friendly
pdf version
The Pharmaceutical Market: Netherlands
static version
printer friendly
pdf version
The Pharmaceutical Market: New Zealand
static version
printer friendly
pdf version
The Pharmaceutical Market: Norway
static version
printer friendly
pdf version
The Pharmaceutical Market: Pakistan
static version
printer friendly
pdf version
The Pharmaceutical Market: Peru
static version
printer friendly
pdf version
The Pharmaceutical Market: Philippines
static version
printer friendly
pdf version
The Pharmaceutical Market: Poland
static version
printer friendly
pdf version
The Pharmaceutical Market: Portugal
static version
printer friendly
pdf version
The Pharmaceutical Market: Romania
static version
printer friendly
pdf version
The Pharmaceutical Market: Russia
static version
printer friendly
pdf version
The Pharmaceutical Market: Saudi Arabia
static version
printer friendly
pdf version
The Pharmaceutical Market: Singapore
static version
printer friendly
pdf version
The Pharmaceutical Market: Slovakia
static version
printer friendly
pdf version
The Pharmaceutical Market: Slovenia
static version
printer friendly
pdf version
The Pharmaceutical Market: South Korea
static version
printer friendly
pdf version
The Pharmaceutical Market: Sweden
static version
printer friendly
pdf version
The Pharmaceutical Market: Switzerland
static version
printer friendly
pdf version
The Pharmaceutical Market: Taiwan
static version
printer friendly
pdf version
The Pharmaceutical Market: UK
static version
printer friendly
pdf version
The Pharmaceutical Market: Ukraine
static version
printer friendly
pdf version
The Pharmaceutical Market: USA
static version
printer friendly
pdf version
The Pharmaceutical Market: Venezuela
static version
printer friendly
pdf version
The Pharmaceutical Mergers and Acquisitions Outlook 2001
static version
printer friendly
pdf version
The Pharmaceutical Parallel Trade Outlook: Challenges To Pharmaceutical Companies Across Europe And The US
static version
printer friendly
pdf version
The Pharmaceutical Pricing and Reimbursement Environment in China
static version
printer friendly
pdf version
The Pharmaceutical Sales Force Outlook: Structures And Strategies To Maximize ROI And Boost Product Uptake
static version
printer friendly
pdf version
The Pharmaceuticals Consumer in the United States 2008
static version
printer friendly
pdf version
The Pharmaceuticals Industry 2007 - Global Market Intelligence Tracking Service
static version
printer friendly
pdf version
The Pharmaceuticals Industry Market Review 2005
static version
printer friendly
pdf version
The Prescribing Data Restriction Program: Critical Assessment and Best Practices
static version
printer friendly
pdf version
The Regulatory Environment for Pharmaceutical Products and Medical Devices in Key Sub-Saharan African Countries
static version
printer friendly
pdf version
The Role of Pharmacogenomics in Personalized Medicine
static version
printer friendly
pdf version
The Role of Self-Medication in Cost-Containment in the United States
static version
printer friendly
pdf version
The Sepsis Market 2003 - Can Analyst Expectation be Met?
static version
printer friendly
pdf version
The Sleep Aids And Remedies Market For Americans Aged 50 And Over
static version
printer friendly
pdf version
The Specialty Pharma Market Outlook: Key Players, New Company Growth Models and Emerging Opportunities
static version
printer friendly
pdf version
The Top 100 Drug Delivery Companies Worldwide
static version
printer friendly
pdf version
The Top 50 Pharmaceutical Manufacturing Companies In Ireland
static version
printer friendly
pdf version
The US Bio-Chip Market for Pharmaceutical Drug Discovery: Technology, Strategic Alliance, Patent Dispute and Market Update, 2002
static version
printer friendly
pdf version
The US Drug Approval Trends and Yearbook 2006/2007
static version
printer friendly
pdf version
The Vaccines Market Outlook: Market Analysis Of Future Growth And Leading Players By Sector
static version
printer friendly
pdf version
The Vioxx Withdrawal: Changes and Opportunities for the Industry
static version
printer friendly
pdf version
The War On Cancer - 2nd Edition
static version
printer friendly
pdf version
The World Market for Addiction Disorders, 2005-2012: New Horizons in High-Profile Dependency Markets
static version
printer friendly
pdf version
The World Pharmaceutical Markets Fact Book 2008
static version
printer friendly
pdf version
The Year in Pharmaceuticals - 2000
static version
printer friendly
pdf version
Therapeutic Categories by Compounds in Development, 2003 vs. 2004
static version
printer friendly
pdf version
Therapeutic Classes by U.S. Prescription Sales, 2003
static version
printer friendly
pdf version
Therapeutic Clinical Intelligence - Type-2 Diabetes Pipeline
static version
printer friendly
pdf version
Therapeutic Vaccines: More Trials and Tribulations
static version
printer friendly
pdf version
Therapies of Tomorrow: Atherosclerotic Disease- Fighting Plaque Attack
static version
printer friendly
pdf version
Thought Leader Compensation: Establishing Fair-Market Value Procedures
static version
printer friendly
pdf version
Thought Leader Insight & Analysis: Alcoholism
static version
printer friendly
pdf version
Thought Leader Insight & Analysis: Alzheimer's Disease
static version
printer friendly
pdf version
Thought Leader Insight & Analysis: Anxiety & Depression
static version
printer friendly
pdf version
Thought Leader Insight & Analysis: Coagulants
static version
printer friendly
pdf version
Thought Leader Insight & Analysis: Gastrointestinal Disorders -- UC, Crohn's, OIC, GERD
static version
printer friendly
pdf version
Thought Leader Insight & Analysis: Obesity
static version
printer friendly
pdf version
Thought Leader Insight & Analysis: Osteoporosis
static version
printer friendly
pdf version
Thought Leader Insight & Analysis: Psoriasis
static version
printer friendly
pdf version
Thought Leader Insight & Analysis: Type 2 Diabetes
static version
printer friendly
pdf version
Thrombosis: Growth opportunities for Antithrombotics and Thrombolytics
static version
printer friendly
pdf version
Top 10 Products Antiulcerant Market
static version
printer friendly
pdf version
Top 200 Drugs by U.S. Sales, 2003
static version
printer friendly
pdf version
Top 200 Drugs by U.S. Sales, 2004
static version
printer friendly
pdf version
Top 200 Indian Pharma Company Profiles
static version
printer friendly
pdf version
Top 30 Pharmaceutical and Biotech Innovators by Patent Grants Obtained, 1998-2003
static version
printer friendly
pdf version
Top 50 Pharmaceutical Companies in the US: A Competitive Analysis (2001 Edition, Vol. 1)
static version
printer friendly
pdf version
Top Categories of U.S. Prescription Drug Spending Percentage Total Sales, 2004
static version
printer friendly
pdf version
Top Categories of U.S. Prescription Drug Spending, 2004
static version
printer friendly
pdf version
Top Five Most Heavily Advertised Drugs
static version
printer friendly
pdf version
Top Pharmaceutical Companies by Number of Products in Development, 2004
static version
printer friendly
pdf version
Top Ten Best Selling Drugs in the World
static version
printer friendly
pdf version
Top Ten Pharmaceutical Companies by U.S. Prescription Sales, 2003
static version
printer friendly
pdf version
Top Ten U.S. Prescription Products by Sales, 2003
static version
printer friendly
pdf version
Top Therapeutic Categories by Number of Drugs in U.S. Development, 2003
static version
printer friendly
pdf version
Top Therapeutic Drug Categories Worldwide by Number of Projects in Development as of March, 2004
static version
printer friendly
pdf version
Top Therapeutic Drug Categories Worldwide by Number of Projects in Development, 2003 and 2004
static version
printer friendly
pdf version
Total Prescriptions for Warfarin, 2002-2006
static version
printer friendly
pdf version
Towards Prescribing Practice
static version
printer friendly
pdf version
Toxicity Biomarkers: Promising Tools for Accelerated Drug Development
static version
printer friendly
pdf version
Traditional Chinese Drug Industry - China 2003
static version
printer friendly
pdf version
Transdermal & Transmucosal Delivery of Therapeutics, 2nd Edition
static version
printer friendly
pdf version
Transgenic manufacturing the whole analysis
static version
printer friendly
pdf version
Translational Medicine: Assessing the Feasibility and Challenges
static version
printer friendly
pdf version
Transmembrane Transporters: High Sales, High Potential as Drug Targets
static version
printer friendly
pdf version
Treating COPD Comorbidities: A Market Opportunity for Systemic Anti-Inflammatory Agents?
static version
printer friendly
pdf version
Treatment Algorithm 2001: Diabetes
static version
printer friendly
pdf version
Treatment Algorithms 2000: Rheumatoid Arthritis - Defining Changing Treatment Trends
static version
printer friendly
pdf version
Treatment Algorithms: Colorectal Cancer 5th Edition - New Gold Standards Emerge But Unmet Need Remains
static version
printer friendly
pdf version
Treatment Algorithms: Hypertension 3rd Edition - Opportunities In Resistant and Hypertensive Sub-Populations
static version
printer friendly
pdf version
Treatment Algorithms: Major Depressive Disorder, 4th Edition - Gaining Competitive Advantage in a Mature Environment
static version
printer friendly
pdf version
Treatment Algorithms: Osteoarthritis 2nd Edition - No Pain, But How Much Gain?
static version
printer friendly
pdf version
Treatment Algorithms: Rheumatoid Arthritis 2nd Edition - Dmards Move to Front of Pack
static version
printer friendly
pdf version
Treatment Trends in Infertility
static version
printer friendly
pdf version
Trends in Cancer Treatment Drugs
static version
printer friendly
pdf version
Trends in Generic Drugs and Diabetes Treatments
static version
printer friendly
pdf version
Trial TRAX - Alzheimer's Disease - Clinical Trial Monitoring Brief
static version
printer friendly
pdf version
Trial TRAX - Rheumatoid Arthritis - Clinical Trial Monitoring Brief
static version
printer friendly
pdf version
Triple Analysis: Melanoma Therapeutics, Antibodies and Vaccines in Oncology
static version
printer friendly
pdf version
Triple Analysis: Non Small Cell Lung Cancer, Protein Kinase Inhibitors & Anti-Angiogenic Agents
static version
printer friendly
pdf version
Triple Analysis: Protein Kinase Inhibitors, Antibodies and Vaccines in Oncology
static version
printer friendly
pdf version
Triple Progress Analysis: Lymphoma Therapeutics, Protein Kinase Inhibitors & Therapeutic Antibodies
static version
printer friendly
pdf version
Tropical Diseases: A Status Update
static version
printer friendly
pdf version
Tuberculosis: A Clinical Timebomb
static version
printer friendly
pdf version
Tuberculosis: Extracting Value From a Stagnant Market
static version
printer friendly
pdf version
Turkey Pharmaceuticals and Healthcare Report Q2 2008
static version
printer friendly
pdf version
Turkey Pharmaceuticals and Healthcare Report Q3 2007
static version
printer friendly
pdf version
Type 2 Diabetes Market Dynamics: Impact of Januvia and Other DPP-IV Inhibitors
static version
printer friendly
pdf version
^ Top
U
U.S. Alzheimer's Disease Medication Markets
static version
printer friendly
pdf version
U.S. Alzheimers Disease Medications Markets
static version
printer friendly
pdf version
U.S. Angioplasty and Vascular Closure Devices Markets
static version
printer friendly
pdf version
U.S. Anti-Obesity Prescription Drug Markets
static version
printer friendly
pdf version
U.S. Anticoagulant and Thrombolytic Pharmaceuticals Markets
static version
printer friendly
pdf version
U.S. Anticoagulant Market
static version
printer friendly
pdf version
U.S. Anticoagulant Pharmaceutical Markets
static version
printer friendly
pdf version
U.S. Anticonvulsant Medications Markets: Indicated and Off-Label Uses
static version
printer friendly
pdf version
U.S. Antidepressant Medications Market
static version
printer friendly
pdf version
U.S. Antifungal Prescription Pharmaceutical Markets
static version
printer friendly
pdf version
U.S. Antipsychotic Medications Markets
static version
printer friendly
pdf version
U.S. Autoimmune Disorders Markets for Biologics
static version
printer friendly
pdf version
U.S. Bio-Computing IT Market Bio-Computing & Pharmaceutical Companies, The Fusion of Computing and Drug Discovery: Technologies, Products, Vendors, Opportunities and Market Forecasts
static version
printer friendly
pdf version
U.S. Biotechnology and Pharmaceutical Analytical Instrumentation Markets
static version
printer friendly
pdf version
U.S. Cardiovascular Pharmaceuticals Markets
static version
printer friendly
pdf version
U.S. Cell-Based Assays Markets
static version
printer friendly
pdf version
U.S. Chronic Obstructive Pulmonary Disease Drug Markets
static version
printer friendly
pdf version
U.S. Combinatorial Chemistry Libraries Market
static version
printer friendly
pdf version
U.S. Congestive Heart Failure Medication Markets
static version
printer friendly
pdf version
U.S. Coronary Stents Markets 2007
static version
printer friendly
pdf version
U.S. Critical Care Antibiotics Markets
static version
printer friendly
pdf version
U.S. Critical Care Drug Markets
static version
printer friendly
pdf version
U.S. Diabetes Medication Markets
static version
printer friendly
pdf version
U.S. Drug Delivery Systems Market: Emerging Technologies, Strategic Alliances, Patent Disputes, Market Size and Forecasts and R&D Activities
static version
printer friendly
pdf version
U.S. Electronic Medical Records (EMR) Markets in Physician-based Practices
static version
printer friendly
pdf version
U.S. Emerging Insulin Delivery Technologies Markets
static version
printer friendly
pdf version
U.S. Emerging Osteoporosis Therapeutics Markets
static version
printer friendly
pdf version
U.S. Ethanol Production, 1980-2005
static version
printer friendly
pdf version
U.S. Generic Pharmaceuticals Outlook
static version
printer friendly
pdf version
U.S. Glaucoma Pharmaceuticals Markets
static version
printer friendly
pdf version
U.S. Health Expenditures as a Percentage of GDP, 1998-2008
static version
printer friendly
pdf version
U.S. Hepatitis Therapy Markets
static version
printer friendly
pdf version
U.S. Hormone Replacement Therapy Markets
static version
printer friendly
pdf version
U.S. Hypolipidemic Prescription Market
static version
printer friendly
pdf version
U.S. Immunoassay Diagnostics Markets
static version
printer friendly
pdf version
U.S. Immunosuppressant Markets
static version
printer friendly
pdf version
U.S. Influenza Pharmaceutical Markets
static version
printer friendly
pdf version
U.S. Insomnia Therapies Markets
static version
printer friendly
pdf version
U.S. Insulin Delivery Market, 2005-2010
static version
printer friendly
pdf version
U.S. Market for Gastrointestinal Disorder Treatments, 2004-2012
static version
printer friendly
pdf version
U.S. Market for Prescription Ophthalmologic Drugs by Type, 2007-2015
static version
printer friendly
pdf version
U.S. Market for Therapeutic Radiopharmaceuticals
static version
printer friendly
pdf version
U.S. Market Share of Statins, 2003
static version
printer friendly
pdf version
U.S. Medical and Pharmaceutical Packaging Markets
static version
printer friendly
pdf version
U.S. Medicinal and Pharmaceutical Imports, 1996-2004
static version
printer friendly
pdf version
U.S. Molecular Diagnostics Markets
static version
printer friendly
pdf version
U.S. Multiple Sclerosis Markets
static version
printer friendly
pdf version
U.S. Neuropathic Pain Medications Markets
static version
printer friendly
pdf version
U.S. Neurotherapeutics Markets
static version
printer friendly
pdf version
U.S. Next Generation Bio-Tools for Accelerating Bio-Pharmaceutical Drug Discovery R&D: Technologies, Opportunities and Markets
static version
printer friendly
pdf version
U.S. Nuclear Medicine Markets
static version
printer friendly
pdf version
U.S. Opioid and Non-Opioid Pain Management Pharmaceuticals Markets